Plasma Fractionation Market Trends, Growth Drivers and Forecast 2026–2035
According to Shivani Zoting, who specializes in biopharmaceuticals, plasma-derived therapies, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, my research indicates that the plasma fractionation market is on a steady growth trajectory, expanding from USD 37.87 billion in 2025 to USD 78.34 billion by 2035 at a 7.54% CAGR. I found that immune globulin and hospital applications currently account for the largest market share, while coagulation factors and retail pharmacies are set to record faster growth. My analysis also highlights North America's market leadership, Europe's accelerating expansion, and the competitive strategies of leading companies such as CSL Behring, Grifols Therapeutics, Takeda Pharmaceutical Company Ltd., Octapharma AG, Syntegon, and Kedrion S.p.A., which continue to shape the industry's future.
Last Updated : 29 June 2026
Category: Biotechnology
Insight Code: 5320
Format: PDF / PPT / Excel